Title and Organization:
Shamiram R. Feinglass, MD, MPH, is the chief medical officer and vice president, global medical affairs and policy at Danaher Corporation. Driving inclusion and diversity in every environment in which she works or leads, Dr. Feinglass leads Global Medical, Government, Reimbursement, and Clinical Affairs for Life Sciences and Diagnostics and is responsible for leading the global pandemic response plan across Danaher. Often working with global leaders and regulators, Dr. Feinglass was formerly the vice president for global medical and regulatory affairs at Zimmer, Inc., has served as a medical officer at the Centers for Medicare and Medicaid Services, in the Coverage and Analysis Group, and as a commander with the U.S. Public Health Service. She has also been clinical faculty at several health sciences universities, and her work has been widely published. A graduate of Smith College, Dr. Feinglass earned her MD and MPH from the Emory Schools of Medicine and Public Health. She completed an internal medicine residency at Oregon Health Sciences University, a preventive medicine residency at Emory School of Medicine, and the Robert Wood Johnson Clinical Scholars Program at the University of Washington. She is board certified in preventive medicine. A sought-after speaker and expert in international medical device and diagnostics policy, Dr. Feinglass has served on a variety of panels for the FDA, FasterCures, The Brookings Institute, Pew Charitable Trusts, Oxford University, and international registry groups. A mother of two, she is currently a BMX state champion and was a member of the USA BMX World Championship Team. Dr. Feinglass is a Fellow of the third class of the Health Innovators Fellowship and a member of the Aspen Global Leadership Network.